Nashville, TN, United States of America

Cheryl L Robinson-Benion

This inventor holds 5 USPTO granted patents. Top assignees: Vanderbilt University, University of Washington, Other. Active years: 1997-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cheryl L Robinson-Benion. Retrieved from https://idiyas.com/inventor/cheryl-l-robinson-benion

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.4

ph-index = 3

Forward Citations = 44(Granted Patents)


Company Filing History:


Years Active: 1997-2002

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Cheryl L Robinson-Benion: Innovator in Cancer Detection and Treatment

Introduction

Cheryl L Robinson-Benion is a prominent inventor based in Nashville, TN (US). She has made significant contributions to the field of cancer research, particularly in the detection and treatment of breast and prostate cancers. With a total of 5 patents to her name, her work has the potential to impact the lives of many patients.

Latest Patents

One of her latest patents is a method for the detection and treatment of breast cancer. This invention provides a method of detecting and diagnosing pre-invasive breast cancer by identifying differentially expressed genes in early, pre-invasive breast cancer tissue. The use of differentially expressed genes as genetic markers can indicate the presence of pre-invasive cancerous tissues. The invention employs microscopically-directed tissue sampling techniques combined with differential display or differential screening of cDNA libraries to determine the differential expression of genes in the early stages of breast cancer. The confirmation of differential expression of genes in pre-invasive breast cancer tissue is achieved through RT-PCR, nuclease protection assays, and in-situ hybridization of ductal carcinoma in situ tissue RNA and control tissue RNA. Additionally, the invention provides a method of screening for compounds that induce expression of the BRCA1 gene, which negatively regulates cell growth in both normal and malignant mammary epithelial cells. Another significant patent involves therapeutic methods for prostate cancer, which includes a gene therapy method using the BRCA family of genes, including BRCA1 and BRCA2. These gene products inhibit the growth and tumorigenesis of prostate cancer cells.

Career Highlights

Cheryl has worked at notable institutions such as Vanderbilt University and the University of Washington. Her research has focused on innovative approaches to cancer treatment, showcasing her dedication to advancing medical science.

Collaborations

Cheryl has collaborated with esteemed colleagues, including Jeffrey T Holt and Roy A Jensen, further enhancing her research and contributions to the field.

Conclusion

Cheryl L Robinson-Benion is a trailblazer in cancer research, with her innovative patents paving the way for new detection and treatment methods. Her work exemplifies the impact of dedicated inventors in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…